EP0717632B1 - Immunstärkendes nahrungsergänzungsmittel - Google Patents
Immunstärkendes nahrungsergänzungsmittel Download PDFInfo
- Publication number
- EP0717632B1 EP0717632B1 EP95917891A EP95917891A EP0717632B1 EP 0717632 B1 EP0717632 B1 EP 0717632B1 EP 95917891 A EP95917891 A EP 95917891A EP 95917891 A EP95917891 A EP 95917891A EP 0717632 B1 EP0717632 B1 EP 0717632B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- oil
- medicinal herb
- herb extracts
- amount
- food supplement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Definitions
- the invention relates to an immune-boosting food supplement.
- the immune system as a whole is the body's own protective system of humans and higher vertebrates to ward off foreign bodies Material. According to the "Lexicon of Biochemistry and Molecular Biology” (Herder-Verlag, Freiburg, Basel, Wien 1991) it is the entirety of all immune cells in an organism, including all immunologically competent organs such as lymph nodes, spleen, thymus, gastrointestinales Lymphoid tissue, bone marrow and humoral components (antibodies). The task of the immune system is in addition to recognizing foreign bodies Material also in the initiation of defense reactions and above in establishing a body's own "immunological memory", with respect to specific antigens.
- the object of the invention is an immune-strengthening dietary supplement to be made available on a plant basis.
- the invention is based on the idea that the positive effects are known
- This synergistic effect will supported by medicinal herbs with detoxifying through the gastrointestinal tract Effect.
- medicinal herbs with the gastrointestinal tract detoxifying effects are therefore particularly preferred.
- Medicinal herbs are plants that due to their ingredients in medicinal herbs (phytotherapy) be used. Medicinal plants traditionally take place in folk medicine an important place, however, medicinal plant science meanwhile is a scientifically based healing method that changes over time who has developed centuries from herbal medicine. Active ingredients of Medicinal plants or medicinal herbs are primarily alkaloids, glycosides, essential oils and the group of tannins and bitter substances. Even today Medicinal plants are the starting point for the production of approx. 55% of all Drug. It is undisputed that this is far from complete Inventory of plants with pharmacologically active ingredients in the tropical forests is one of the true treasures of centuries.
- an alcoholic (ethanolic) medicinal herb extract used. This can consist of about 20% by weight of ethanol and the rest extracted solid substances exist.
- the alcoholic (ethanolic) medicinal herb extracts combined with vegetable oils containing eugenol according to the claims.
- vegetable oil provides a collective name for essential oils or essences represents by physical processes from plants or parts of plants can be won. In general, these are distillative processes, for example steam distillation. Freshly harvested plant parts are either directly or after mixing extracted with water by steam distillation. When mixing with water (mashing) there can be some fermentation processes come in which degradation reactions take place to a certain extent. After Condensation of the vapors collects the distillate and the so obtained essential oil, optionally by repeated distillation with Rectified water vapor.
- eugenol-containing vegetable oils or essential oils are used.
- Eugenol (4-allyl-2-methoxyphenol, C 12 H 12 O 2 ) is a constituent of numerous essential oils and is contained, for example, in clove oil with 80%, in pimento berry oil with 60 to 90% and in bay oil with 60%.
- alcoholic (ethanolic) herbal extracts and the Vegetable oils containing eugenol contain an immune-boosting agent according to the invention Dietary supplements and, if appropriate, customary stabilizing agents and additives.
- Extracts of medicinal herbs are preferred which are used via the gastrointestinal tract detoxify.
- the detoxification of the gastrointestinal tract is included a function that supports the immune system.
- a detoxification is going through Improvement of muscle tension and thus the elasticity of the stomach and Intestinal walls reached. This speeds up the intestinal flow and toxins no longer have the opportunity to damage the intestinal walls for a long time to act on the organism.
- Preferred medicinal herb extracts according to the invention are extracts from aloe, Myrrh, safflower, senna leaves, manna, boar root, angelica root, camphor, Zittwerwurzel, Theriak, nettle, calendula, bedstraw, sauerklle, Calamus, celandine, mallow, willow herb, yarrow, mistletoe, horsetail, Rosemary, sage and marjoram.
- These medicinal herbs are examples of those with the gastrointestinal tract detoxifying effect.
- Preferred eugenol-containing vegetable oils according to the invention are clove oil, Allspice oil, bay oil, bay leaf oil, basil oil, eucalyptus oil and citronella oil.
- Medicinal Herb Extracts Abbr. Surname Latin name H 1 aloe aloe ferox H 2 myrrh myrrha H 3 Safflower flores carthami H 4 Senna leaves folia sennae H 5 manna manna H 6 Boar root radix carlinae H 7 Angelica root radix angelicae H 8 Fighter camphora H 9 Zittwer root rhizoma zedoariae H10 Theriak electuarium theriaca H11 Nettle urtica dioica H12 Marigold calendula officinalis H13 Bedstraw galium verum H14 Sour clover oxalis acetosella H15 Calamus acorus calanus H16 Celandine chelidonium majus H17 Mallow malva vulgaris H18
- the medicinal herb extracts H1 to H24 or eugenol-containing essential oils E1 to E7 can be combined with one another in any desired manner, but six embodiments of the invention, which result from Table II below, are particularly preferred.
- the components H and E used in each case are denoted by an "x”.
- Embodiment 1 abundant diluted with tea or fruit juice.
- the immunostabilizing food supplement 40 preferably contains up to 60 parts by weight of herbal extracts to 60 to 40 parts by weight Vegetable oils, particularly preferably 45 to 55 parts by weight of medicinal herb extracts to 55 to 45 parts by weight of vegetable oils. Because of the ethanol content the medicinal herb extracts contain such a mixture 8 to 12% by weight Ethanol based on the total of medicinal herb ingredients, vegetable oils and ethanol, the rest (92 to 88% by weight) make up the sum Medicinal herb ingredients and vegetable oils.
- the individual medicinal herb extracts are preferably essentially to one another same amount available, but alternatively aloe this amount increased and safflower can be so low at the same time that the elevation and the humiliation balance out.
- the essential oils are divided so that each oil without Consideration of clove oil with 10 to 12% by weight is present and Clove oil does the rest.
- the pharmaceutical production of the immune-boosting food supplement is done by mixing the ethanolic medicinal herb extracts and the Vegetable oils containing eugenol in the intended ratio. It two phases are formed, which can be homogenized by shaking, however, segregation occurs again after standing for a long time.
- a homogeneous, dispersed phase can be added by adding an emulsifier (e.g. lecithin) be stabilized. Generally, however, an emulsifier is used waived.
- the dietary supplement should be made before Ingestion can be homogenized by shaking.
- Liquid e.g. warm tea or fruit juice
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
Description
Heilkräuterextrakte (H) | ||
Abk. | Name | lat. Bezeichnung |
H 1 | Aloe | aloe ferox |
H 2 | Myrrhe | myrrha |
H 3 | Saflor | flores carthami |
H 4 | Sennesblätter | folia sennae |
H 5 | Manna | manna |
H 6 | Eberwurz | radix carlinae |
H 7 | Angelikawurzel | radix angelicae |
H 8 | Kampfer | camphora |
H 9 | Zittwerwurzel | rhizoma zedoariae |
H10 | Theriak | electuarium theriaca |
H11 | Brennessel | urtica dioica |
H12 | Ringelblume | calendula officinalis |
H13 | Labkraut | galium verum |
H14 | Sauerklee | oxalis acetosella |
H15 | Kalmus | acorus calanus |
H16 | Schöllkraut | chelidonium majus |
H17 | Wegmalve | malva vulgaris |
H18 | Weidenröschen | epilosbium roseum |
H19 | Schafgarbe | achillea milleflorum |
H20 | Mistel | viscum alba |
H21 | Zinnkraut | equisetum arvense |
H22 | Rosmarin | rosmarinus officinalis |
H23 | Salbei | salvia officinalis |
H24 | Majoran | origanum majorana |
Eugenolhaltige etherische Öle (E) | ||
Abk. | Name | lat. Bezeichnung |
E 1 | Nelken-Öl | eugenia caryophyllata |
E 2 | Pimentbeeren-Öl | pimento officinalis |
E 3 | Bay-Öl | pimento racemosa |
E 4 | Lorbeerblätter-Öl | laurus nobilis |
E 5 | Basilikum-Öl | ocimunm basilicum |
E 6 | Eukalyptus-Öl | eucalyptus globulus |
E 7 | Citronella-Öl | cymbopogon winterianus |
Heilkräuterextrakte (H) | Ausführungsform | |||||||
1 | 2 | 3 | 4 | 5 | 6 | |||
Abk. | Name | lat. Bezeichnung | enthalten (x) | |||||
H 1 | Aloe | aloe ferox | x | x | x | x | x | x |
H 2 | Myrrhe | myrrha | x | x | x | x | x | x |
H 3 | Saflor | flores carthami | x | x | x | x | x | x |
H 4 | Sennesblätter | folia sennae | x | x | x | x | x | x |
H 5 | Manna | manna | x | x | x | x | x | x |
H 6 | Eberwurz | radix carlinae | x | x | x | x | x | x |
H 7 | Angelikawurzel | radix angelicae | x | x | x | x | x | x |
H 8 | Kampfer | camphora | x | x | x | x | x | x |
H 9 | Zittwerwurzel | rhizoma zedoariae | x | x | x | x | x | x |
H10 | Theriak | electuarium theriaca | x | x | x | x | x | x |
H11 | Brennessel | urtica dioica | x | x | x | |||
H12 | Ringelblume | calendula officinali | x | x | x | |||
H13 | Labkraut | galium verum | x | x | x | |||
H14 | Sauerklee | oxalis acetosella | x | |||||
H15 | Kalmus | acorus calanus | x | x | x | |||
H16 | Schöllkraut | chelidonium majus | x | x | x | x | ||
H17 | Wegmalve | malva vulgaris | x | x | x | |||
H18 | Weidenröschen | epilosbium roseum | x | x | ||||
H19 | Schafgarbe | achillea milleflorum | x | x | ||||
H20 | Mistel | viscum alba | x | x | x | x | ||
H21 | Zinnkraut | equisetum arvense | x | x | ||||
H22 | Rosmarin | rosmarinus officinalis | x | |||||
H23 | Salbei | salvia officinalis | x | |||||
H24 | Majoran | origanum majorana | x | |||||
Eugenolhaltige Etherische Öle (E) | ||||||||
Abk. | Name | lat. Bezeichnung | ||||||
E 1 | Nelken-Öl | eugenia caryophyllata | x | x | x | x | x | x |
E 2 | Pimentbeeren-Öl | pimento officinalis | x | |||||
E 3 | Bay-Öl | pimento racemosa | x | x | ||||
E 4 | Lorbeerblätter-Öl | laurus nobilis | x | x | x | x | ||
E 5 | Basilikum-Öl | ocimunm basilicum | x | x | ||||
E 6 | Eukalyptus-Öl | eucalyptus globulus | x | x | ||||
E 7 | Citronella-Öl | cymbopogon winterianus | x | x | x |
Claims (11)
- Immunstärkendes Nahrungsergänzungsmittel, entaltend einen oder mehrere ethanolische Heilkräuterextrakte, ein oder mehrere eugenolhaltige Pflanzen-öle sowie gegebenenfalls übliche Stabilisierungsmittel und Zusatzstoffe enthält,
gekennzeichnet durch(a) 40 bis 60 Gewichtsteile der Heilkräuterextrakte von Aloe, Myrrhe, Saflor, Sennesblätter, Manna, Eberwurz, Angelikawurzel, Kampfer, Zittwerwurzel und Theriak und(b) 60 bis 40 Gewichtsteile des Pflanzenöls Nelken-Öl, wobei(c) die Heilkräuterextrakte untereinander in im wesentlichen gleicher Menge vorhanden sind. - Nahrungsergänzungsmittel nach Anspruch 1, dadurch gekennzeichnet, daß zusätzlich die Heilkräuterextrakte von Brennessel und Mistel in im wesentlichen gleicher Menge wie die anderen Heilkräuterextrakte vorhanden sind.
- Nahrungsergänzungsmittel nach Anspruch 1 oder 2, dadurch gekennzeichnet daß zusätzlich die Heilkräuterextrakte von Ringelblume, Labkraut, Schöllkraut, Wegmalve und Mistel in im wesentlichen gleicher Menge wie die anderen Heilkräuterextrakte vorhanden sind und zusätzlich das Pflanzenöl Lorbeerblätter-Öl vorhanden ist, wobei die Menge des zusätzlichen Pflanzen-Öls 10 bis 12 Gew.-% der Menge des Nelken-Öls beträgt.
- Nahrungsergänzungsmittel nach Anspruch 1, dadurch gekennzeichnet, daß zusätzlich die Heilkräuterextrakte von Labkraut, Kalmus, Schöllkraut, Weidenröschen, Mistel und Zinnkraut in im wesentlichen gleicher Menge wie die anderen Heilkräuterextrakte vorhanden sind und zusätzlich die Pflanzen-öle Lorbeerblätter-Öl, Eukalyptus-Öl und Citronella-Öl vorhanden sind, wobei die Menge der zusätzlichen Pflanzen-Öle jeweils 10 bis 12 Gew.-% der Menge des Nelken-Öls beträgt.
- Nahrungsergänzungsmittel nach Anspruch 1, dadurch gekennzeichnet, daß zusätzlich die Heilkräuterextrakte von Brennessel, Ringelblume, Kalmus, Schöllkraut, Wegmalve und Schafgarbe in im wesentlichen gleicher Menge wie die anderen Heilkräuterextrakte vorhanden sind und zusätzlich die Pflanzenöle Bay-Öl, Lorbeerblätter-ÖI, Basilikum-Öl und Citronella-Öl vorhanden sind, wobei die Menge der zusätzlichen Pflanzen-Öle jeweils 10 bis 12 Gew.-% der Menge des Nelken-Öls beträgt.
- Nahrungsergänzungsmittel nach Anspruch 1, dadurch gekennzeichnet, daß zusätzlich die Heilkräuterextrakte von Brennessel, Ringelblume, Labkraut, Sauerklee, Kalmus, Schöllkraut, Wegmalve, Weidenröschen, Schafgarbe, Mistel, Zinnkraut, Rosmarin, Salbei und Majoran in im wesentlichen gleicher Menge wie die anderen Heilkräuterextrakte vorhanden sind und zusätzlich die Pflanzenöle Pimentbeeren-Öl, Bay-Öl, Lorbeerblätter-Öl, Basilikum-Öl, Eukalyptus-Öl und Citronella-Öl vorhanden sind, wobei die Menge der zusätzlichen Pflanzen-Öle jeweils 10 bis 12 Gew.-% der Menge des Nelken-Öls beträgt.
- Nahrungsergänzungsmittel nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es bezogen auf die Summe aus Heilkräuter-lnhaltsstoffen, Pflanzenölen und Ethanol 8 bis 12 Gew-% Ethanol und 92 bis 88 Gew-% Heilkräuter-Inhaltsstoffe plus Pflanzenöle enthält.
- Nahrungsergänzungsmittel nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es einen Emulgator enthält.
- Nahrungsergänzungsmittel nach Anspruch 9, dadurch gekennzeichnet, daß der Emulgator Lecithin ist.
- Nahrungsergänzungsmittel nach einem der Ansprüche 1 bis 9, dadurch gekennzeichnet, daß Aloe gegenüber der Menge gemäß Merkmal (c) erhöht und gleichzeitig Saflor so erniedrigt ist, daß sich die Erhöhung und die Erniedrigung ausgleichen.
- Nahrungsergänzungsmittel nach einem der Ansprüche 2 bis 10, gekennzeichnet durch 45 bis 55 Gewichtsteile Heilkräuterextrakte auf 55 bis 45 Gewichtsteile Pflanzenöl(e).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4416402A DE4416402A1 (de) | 1994-05-09 | 1994-05-09 | Immunstärkendes Nahrungsergänzungsmittel |
DE4416402 | 1994-05-09 | ||
PCT/DE1995/000605 WO1996005848A1 (de) | 1994-05-09 | 1995-05-09 | Immunstärkendes nahrungsergänzungsmittel |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0717632A1 EP0717632A1 (de) | 1996-06-26 |
EP0717632B1 true EP0717632B1 (de) | 2001-10-17 |
Family
ID=6517728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95917891A Expired - Lifetime EP0717632B1 (de) | 1994-05-09 | 1995-05-09 | Immunstärkendes nahrungsergänzungsmittel |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0717632B1 (de) |
JP (1) | JPH09502455A (de) |
AT (1) | ATE206928T1 (de) |
BR (1) | BR9506040A (de) |
CA (1) | CA2166285A1 (de) |
DE (2) | DE4416402A1 (de) |
ES (1) | ES2165912T3 (de) |
WO (1) | WO1996005848A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000012640A (ko) * | 1999-12-15 | 2000-03-06 | 주육현 | 면역기능을 강화시킨 홀몬파워 제조 |
JP4534003B2 (ja) * | 2001-08-30 | 2010-09-01 | 学校法人日本大学 | 抗アレルギー作用を有する健康食品 |
US6488957B1 (en) | 2001-12-17 | 2002-12-03 | Teddy A. Koumarianos | Food additive composition |
CA2493320C (en) * | 2002-07-25 | 2012-05-22 | Ricola Ag | Confectionery made from herbal mixtures |
ATE354075T1 (de) † | 2003-10-22 | 2007-03-15 | Micro Motion Inc | Diagnostisches gerät und verfahren für einen durchflussmesser nach dem coriolisprinzip |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03255031A (ja) * | 1990-03-02 | 1991-11-13 | Taiyo Koryo Kk | 歯周病予防組成物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3447572A1 (de) * | 1984-12-22 | 1986-07-03 | Wolfgang Wirth | Mittel zur regenerierung und staerkung tierischer und menschlicher organismen koerpereigener abwehrkraefte und der haut sowie zu deren schutz aus aloe-wirkstoffen |
EP0391886A1 (de) * | 1989-03-28 | 1990-10-10 | Peter Lenauer | Nahrungs- bzw. Futterzusatzmittel |
JPH0453895A (ja) * | 1990-06-21 | 1992-02-21 | T Hasegawa Co Ltd | 天然抗酸化剤の製造法 |
RU2000793C1 (ru) * | 1992-03-17 | 1993-10-15 | Мошанова Нина Сергеевна, Мошанов Василий Иванович; Череватый Борис Сергеевич | Сбор, обладающий антидиабетическим действием |
-
1994
- 1994-05-09 DE DE4416402A patent/DE4416402A1/de not_active Ceased
-
1995
- 1995-05-09 JP JP8502692A patent/JPH09502455A/ja active Pending
- 1995-05-09 EP EP95917891A patent/EP0717632B1/de not_active Expired - Lifetime
- 1995-05-09 AT AT95917891T patent/ATE206928T1/de not_active IP Right Cessation
- 1995-05-09 CA CA002166285A patent/CA2166285A1/en not_active Abandoned
- 1995-05-09 WO PCT/DE1995/000605 patent/WO1996005848A1/de active IP Right Grant
- 1995-05-09 BR BR9506040A patent/BR9506040A/pt not_active Application Discontinuation
- 1995-05-09 ES ES95917891T patent/ES2165912T3/es not_active Expired - Lifetime
- 1995-05-09 DE DE59509720T patent/DE59509720D1/de not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03255031A (ja) * | 1990-03-02 | 1991-11-13 | Taiyo Koryo Kk | 歯周病予防組成物 |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Week 199201, Derwent World Patents Index; AN 1992-002621 * |
Also Published As
Publication number | Publication date |
---|---|
ES2165912T3 (es) | 2002-04-01 |
JPH09502455A (ja) | 1997-03-11 |
BR9506040A (pt) | 1996-08-06 |
ATE206928T1 (de) | 2001-11-15 |
EP0717632A1 (de) | 1996-06-26 |
DE59509720D1 (de) | 2001-11-22 |
WO1996005848A1 (de) | 1996-02-29 |
CA2166285A1 (en) | 1995-11-10 |
DE4416402A1 (de) | 1995-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3705151C2 (de) | ||
DE69836321T2 (de) | Pflanzenextrakte mit appetitzügelnder Aktivität | |
DE69907606T2 (de) | Zusammensetzung, die Panax pseudo ginseng und Eucommiae ulmoides enthält | |
DE60117711T2 (de) | Antineoplastisches arzneimittel | |
DE3348164C2 (de) | ||
DE69936307T2 (de) | Verringerung der homocysteinkonzentration im serum mittels allium und vitaminen | |
EP0717632B1 (de) | Immunstärkendes nahrungsergänzungsmittel | |
DE19716660C2 (de) | Zubereitungen, insbesondere pharmazeutische, und Arzneiformen auf pflanzlicher Basis zur Bekämpfung von Helicobacter pylori-Infektionen | |
EP1021198B1 (de) | Flavonolignan-zubereitungen, insbesondere silymarin-zubereitungen | |
DE19821971C2 (de) | Arzneimittel zur Behandlung von Psoriasis oder Neurodermitis | |
DE60206545T2 (de) | Zusammensetzung zum Trinken/Essen enthaltend AGARICUS BLAZEI MURRILL | |
DE3931693C2 (de) | ||
DE3508875A1 (de) | Verfahren und praeparat zur stimulierung des immunsystems | |
DE879007C (de) | Verfahren zur Gewinnung von Bienenprodukten honigartiger Konsistenz mit besondere Wirkung | |
DE3905033A1 (de) | Extrakt, arzneimittel | |
DE2611979B2 (de) | Mittel zur Behandlung von Blähungen und Durchfall bei Tieren | |
DE2753140C2 (de) | Arzneimittel zur Behandlung von Magengeschwüren | |
DE3809427A1 (de) | Verwendung von samen des niem - baums zur prophylaxe und therapie viraler infektionen | |
DE4111782A1 (de) | Verwendung von bienenkittharz | |
DE3303398C2 (de) | ||
DE60206467T2 (de) | Entgiftende phytotherapeutische Zusammensetzung aus zwei Pflanzenextrakten und Verfahren zu deren Herstellung | |
DE2905669C2 (de) | ||
DE3304500C2 (de) | Verwendung von diätetischen Nahrungsmitteln auf der Basis von Milch und Banane zur Behandlung von Psoriasis | |
DE102022115137A1 (de) | Zusammensetzung mit hepatoprotektiver Wirkung | |
DE2753466A1 (de) | Verwendung von extrakten von pflanzen der art prunus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19960209 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT CH DE ES FR GB IT LI SE |
|
17Q | First examination report despatched |
Effective date: 19990920 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: CARL, HELMUT |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT CH DE ES FR GB IT LI SE |
|
REF | Corresponds to: |
Ref document number: 206928 Country of ref document: AT Date of ref document: 20011115 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REF | Corresponds to: |
Ref document number: 59509720 Country of ref document: DE Date of ref document: 20011122 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: PATENTANWAELTE SCHAAD, BALASS, MENZL & PARTNER AG |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 20020117 |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2165912 Country of ref document: ES Kind code of ref document: T3 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20020415 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20020517 Year of fee payment: 8 Ref country code: ES Payment date: 20020517 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20020523 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20020524 Year of fee payment: 8 Ref country code: CH Payment date: 20020524 Year of fee payment: 8 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030509 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030509 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030510 Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030510 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030531 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030531 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20030509 |
|
EUG | Se: european patent has lapsed | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040130 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20030510 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20050503 Year of fee payment: 11 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20050509 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20061201 |